Immix Biopharma on Track to Dose NXC-201 Patients in United States
Scheduling U.S. site initiation visits April and May 2024 On track to dose relapsed/refractory AL Amyloidosis patients with CAR-T NXC-201 […]
Scheduling U.S. site initiation visits April and May 2024 On track to dose relapsed/refractory AL Amyloidosis patients with CAR-T NXC-201 […]
New Potato Farmer Advisor: Chad Berry Media/PR Update WATERLOO, Ontario, April 18, 2024 (GLOBE NEWSWIRE) — FuelPositive Corporation, a leading […]
The addition of the Clayton site in 2011 marked a new milestone for Grifols, turning the company into a top-three […]
COSTA MESA, CA., April 18, 2024 (GLOBE NEWSWIRE) — Clean Energy Technologies, Inc. (Nasdaq: CETY) (“CETY” or the “Company”), a […]
ATHENS, Greece, April 18, 2024 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing […]
FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a clinical-stage biopharmaceutical […]
BEIJING, China, April 18, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), […]
MILFORD, Del., April 18, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient […]